Bone Loss: Clinical Trials

9 trials for Bone Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 9

Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Regenerative Potential of Advanced Platelet Rich Fibrin and Bioactive Glass (Perioglas®).
open flap debridement and filled with A-PRF ( Advanced platelet rich fibrin), open flap debridement and filled with Bioactive glass (Perioglas®), open flap debridement and filled Bioactive glass (Perioglas®) and A-PRF - Chronic Periodontitis, Bone Loss
Phase 4CompletedMaharishi Markendeswar University (Deemed to be University)482020-12-012022-11-08
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
Denosumab, Placebo, Zoledronic Acid - Bariatric Surgery Candidate, Bone Loss
Phase 4CompletedMassachusetts General Hospital362020-08-242025-10-29
Influence of the Implant Connection on Facial Tissues Maturation
implantology - Bone Loss, Periodontal Bone Loss
Phase 4CompletedUniversity of Milan1042018-11-012019-11-14
Weight Loss With Risedronate for Bone Health
Risedronate Sodium 150 MG, Placebo - Bariatric Surgery Candidate, Bone Loss
Phase 4CompletedWake Forest University Health Sciences242018-06-152021-02-09
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
teriparatide, weight-bearing - Osteoporosis, Bone Loss
Phase 4CompletedThomas J. Schnitzer122009-06-012013-07-11
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
risedronate - Bone Loss, Osteoporosis
Phase 4CompletedSusan L. Greenspan1092007-09-012017-10-13
Antiepileptic Drugs and Osteoporotic Prevention Trial
Risedronate, Placebo + Calcium and Vitamin D - Epilepsy, Bone Loss
Phase 4CompletedBoston VA Research Institute, Inc.802006-06-012015-07-24
Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty
Risedronate, Placebo - Bone Loss
Phase 4CompletedDanderyd Hospital782006-04-012014-09-19
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Pamidronate - Bone Loss
Phase 4CompletedNovartis Pharmaceuticals1262000-06-012010-05-17

Narrower conditions

Bone Diseases, Metabolic (9)  ·  Osteoporosis (3)  ·  Alveolar Bone Loss (1)  ·  Breast Neoplasms (1)  ·  Chronic Periodontitis (1)  ·  Epilepsy (1)  ·  Fractures, Bone (1)  ·  Seizures (1)  ·  Spinal Cord Injuries (1)  ·  Weight Loss (1)

Broader conditions

Bone Diseases (9)  ·  Metabolic Diseases (9)  ·  Musculoskeletal Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Central Nervous System Diseases (2)  ·  Mouth Diseases (2)  ·  Nervous System Diseases (2)  ·  Periodontal Diseases (2)  ·  Signs and Symptoms (2)  ·  Stomatognathic Diseases (2)  ·  Wounds and Injuries (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Bone Resorption (1)

Interventions

Risedronic Acid (4)  ·  Bioglass (1)  ·  Calcium (1)  ·  Denosumab (1)  ·  Exercise (1)  ·  Pamidronate (1)  ·  Teriparatide (1)  ·  Vitamin D (1)  ·  Weight-Bearing (1)  ·  Zoledronic Acid (1)

Sponsors

Boston VA Research Institute, Inc. (1)  ·  Danderyd Hospital (1)  ·  Maharishi Markendeswar University (Deemed to be University) (1)  ·  Massachusetts General Hospital (1)  ·  Novartis Pharmaceuticals (1)  ·  Susan L. Greenspan (1)  ·  Thomas J. Schnitzer (1)  ·  University of Milan (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (5)  ·  India (1)  ·  Italy (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Antonio A Lazzari, MD (1)  ·  John Cunningham, MD (1)  ·  Kristen M Beavers, PhD (1)  ·  Manisha Thakore, MD (1)  ·  Phillip Dussault, Pharm D (1)  ·  Susan L. Greenspan, MD (1)  ·  Thomas J Schnitzer, MD, PhD (1)

Results publications

PMID 19393473, PMID 32066431, PMID 33103032, PMID 38979716